radiolabeled antibodies (University of Sydney/ANSTO)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Nameradiolabeled antibodies (University of Sydney/ANSTO)

Drug Alias Name[64]-Cu-DAHA-B72.3[64]Cu-SarAr-Ch14.18

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateRadiation-emitting products > Radioactive diagnostic agent

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity of Sydney

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAustralian Nuclear Science And Technology Organisation University of Sydney

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A